# Wuxi Capital

> Wuxi Capital is a VC fund in Wuxi Shi backing Manufacturing, Medical and Health Care. See 58 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Wuxi Shi, China
- Total investments: 58
- Last investment: Feb 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E6%97%A0%E9%94%A1%E5%B8%82%E9%87%91%E8%9E%8D%E6%8A%95%E8%B5%84%E6%9C%89%E9%99%90%E8%B4%A3%E4%BB%BB%E5%85%AC%E5%8F%B8
- Website: http://www.wxfig.com/

Wuxi Capital is a financial investment platform.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 15 | 26% |
| Medical | 12 | 21% |
| Health Care | 12 | 21% |
| Biotechnology | 11 | 19% |
| Semiconductor | 11 | 19% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 18 | 31% |
| Series B | 16 | 28% |
| Angel | 8 | 14% |
| Series A | 8 | 14% |
| Series C | 4 | 7% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 48 | 83% |
| United States | 3 | 5% |
| Germany | 1 | 2% |
| Hong Kong | 1 | 2% |
| Singapore | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Diantui Technology | Diantui Technology is a satellite electric thruster supplier that specialises in the research and development of Hall thrusters, ion thrusters, pulsed plasma thrusters, and other related products |  | Angel | Feb 26, 2026 |  |
| MetaSilicon | MetaSilicon’s focus on edge computing could make a significant impact in various industries by enabling faster data processing closer to where it’s generated. | $43.2M | Series A | Feb 05, 2026 |  |
| Zhihang Spacetime | Zhihang Spacetime provides "satellite + 5G" integrated antenna and communication and navigation solutions. |  | Angel | Jul 18, 2025 |  |
| Gritworld | Push the boundaries of real time graphics and computer visionThey facilitate seamless data transfer from industry standard data formats to real time high quality computer graphics and vision engines formats, in order to dramatically improve the efficiency and quality of real time data simulation, visualization and standardization.They helpindustry technology leaders to research and develop key technologies in computer graphics and vision, VR and AR. |  | Series B | Jul 17, 2025 |  |
| Zhongdi Semiconductor | Zhongdi Semiconductor specializes in indium phosphide (InP) single crystals essential for optical communication and integrated circuits. |  | Angel | Jun 17, 2025 |  |
| Gaze Technology | Gaze Technology is an innovative company specializing in the development of near-space aerostats—high-altitude, lighter-than-air platforms designed for operations in the stratosphere. |  | Seed | Jun 05, 2025 |  |
| Zelos | Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models. | $200M | Series B | Apr 15, 2025 |  |
| RoboCT | RoboCT is an enterprise integrating robot technology, software design and development company. | $13.8M | Series B | Mar 27, 2025 |  |
| Insilico Medicine | Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and,unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digital medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI. | $123M | Series E | Mar 13, 2025 |  |
| Weimai Medical | Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions. | $99M | Series B | Feb 17, 2025 |  |

10 of 58 investments shown.

## Co-investors
- [AstraZeneca-CICC Venture Capital](https://shizune.co/investors/profile/astrazeneca-cicc-venture-capital) — VC Fund, 2 deals together
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 2 deals together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 2 deals together
- [Chengdu Airport](https://shizune.co/investors/profile/chengdu-airport) — VC Fund, 2 deals together
- [China Structural Reform Fund](https://shizune.co/investors/profile/china-structural-reform-fund) — VC Fund, 2 deals together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)
- [Finance Investors in China](https://shizune.co/investors/finance-investors-china)
- [Finance VC Funds in China](https://shizune.co/investors/finance-vc-funds-china)

## FAQ

### What does Wuxi Capital invest in?

Wuxi Capital invests primarily in Manufacturing, Medical and Health Care startups, most often at Seed and Series B stage. Most of the 58 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Wuxi Capital last invest?

The most recent investment recorded for Wuxi Capital closed in Feb 2026. Shizune tracks 58 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co